nodes	percent_of_prediction	percent_of_DWPC	metapath
Menadione—F2—Captopril—systemic scleroderma	0.363	0.489	CbGbCtD
Menadione—XDH—Azathioprine—systemic scleroderma	0.165	0.222	CbGbCtD
Menadione—MTHFR—Methotrexate—systemic scleroderma	0.0937	0.126	CbGbCtD
Menadione—AOX1—Methotrexate—systemic scleroderma	0.0622	0.084	CbGbCtD
Menadione—CYP1A2—Pentoxifylline—systemic scleroderma	0.0296	0.04	CbGbCtD
Menadione—GGCX—cardial valve—systemic scleroderma	0.0284	0.165	CbGeAlD
Menadione—CYP1A2—Leflunomide—systemic scleroderma	0.0283	0.0382	CbGbCtD
Menadione—F2—cardial valve—systemic scleroderma	0.0181	0.105	CbGeAlD
Menadione—BGLAP—forelimb zeugopod—systemic scleroderma	0.0158	0.0915	CbGeAlD
Menadione—BGLAP—skeletal joint—systemic scleroderma	0.0104	0.0606	CbGeAlD
Menadione—F7—artery—systemic scleroderma	0.00748	0.0435	CbGeAlD
Menadione—F7—endothelium—systemic scleroderma	0.00632	0.0367	CbGeAlD
Menadione—F9—endothelium—systemic scleroderma	0.00604	0.0351	CbGeAlD
Menadione—F7—blood vessel—systemic scleroderma	0.00583	0.0338	CbGeAlD
Menadione—F9—blood vessel—systemic scleroderma	0.00557	0.0323	CbGeAlD
Menadione—VKORC1—artery—systemic scleroderma	0.00366	0.0212	CbGeAlD
Menadione—F7—connective tissue—systemic scleroderma	0.00299	0.0174	CbGeAlD
Menadione—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—COL1A2—systemic scleroderma	0.00293	0.0338	CbGpPWpGaD
Menadione—PROC—Beta2 integrin cell surface interactions—ITGAM—systemic scleroderma	0.00288	0.0332	CbGpPWpGaD
Menadione—F9—connective tissue—systemic scleroderma	0.00286	0.0166	CbGeAlD
Menadione—VKORC1—blood vessel—systemic scleroderma	0.00285	0.0165	CbGeAlD
Menadione—MTHFR—artery—systemic scleroderma	0.00272	0.0158	CbGeAlD
Menadione—F2—artery—systemic scleroderma	0.00272	0.0158	CbGeAlD
Menadione—F10—Beta2 integrin cell surface interactions—TGFBI—systemic scleroderma	0.00268	0.0309	CbGpPWpGaD
Menadione—PROC—digestive system—systemic scleroderma	0.00246	0.0143	CbGeAlD
Menadione—F2—endothelium—systemic scleroderma	0.00229	0.0133	CbGeAlD
Menadione—F7—digestive system—systemic scleroderma	0.00216	0.0125	CbGeAlD
Menadione—F7—Folate Metabolism—CSF1—systemic scleroderma	0.00215	0.0248	CbGpPWpGaD
Menadione—F2—blood vessel—systemic scleroderma	0.00212	0.0123	CbGeAlD
Menadione—MTHFR—blood vessel—systemic scleroderma	0.00212	0.0123	CbGeAlD
Menadione—F9—digestive system—systemic scleroderma	0.00206	0.012	CbGeAlD
Menadione—F10—Beta2 integrin cell surface interactions—ITGAM—systemic scleroderma	0.00194	0.0224	CbGpPWpGaD
Menadione—VKORC1L1—tendon—systemic scleroderma	0.00194	0.0112	CbGeAlD
Menadione—NQO1—Validated transcriptional targets of TAp63 isoforms—GDF15—systemic scleroderma	0.00181	0.0209	CbGpPWpGaD
Menadione—F7—lung—systemic scleroderma	0.0018	0.0105	CbGeAlD
Menadione—BGLAP—connective tissue—systemic scleroderma	0.00175	0.0101	CbGeAlD
Menadione—AOX1—Effects of Nitric Oxide—NOS3—systemic scleroderma	0.00173	0.0199	CbGpPWpGaD
Menadione—F9—lung—systemic scleroderma	0.00172	0.01	CbGeAlD
Menadione—VKORC1L1—lung—systemic scleroderma	0.0017	0.00987	CbGeAlD
Menadione—PROC—Beta2 integrin cell surface interactions—CD40LG—systemic scleroderma	0.0017	0.0196	CbGpPWpGaD
Menadione—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—SMAD7—systemic scleroderma	0.00164	0.0189	CbGpPWpGaD
Menadione—PROS1—connective tissue—systemic scleroderma	0.00162	0.00939	CbGeAlD
Menadione—XDH—Effects of Nitric Oxide—NOS3—systemic scleroderma	0.00161	0.0185	CbGpPWpGaD
Menadione—PROS1—Platelet degranulation—SELP—systemic scleroderma	0.00142	0.0163	CbGpPWpGaD
Menadione—PROC—Cell surface interactions at the vascular wall—SELP—systemic scleroderma	0.00135	0.0156	CbGpPWpGaD
Menadione—PROS1—Response to elevated platelet cytosolic Ca2+—SELP—systemic scleroderma	0.00135	0.0156	CbGpPWpGaD
Menadione—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—systemic scleroderma	0.00133	0.0154	CbGpPWpGaD
Menadione—BGLAP—Glucocorticoid receptor regulatory network—IL13—systemic scleroderma	0.00132	0.0153	CbGpPWpGaD
Menadione—MAOB—Alpha-synuclein signaling—BLK—systemic scleroderma	0.00126	0.0145	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—TOP1—systemic scleroderma	0.00124	0.0143	CbGpPWpGaD
Menadione—GGCX—digestive system—systemic scleroderma	0.00123	0.00714	CbGeAlD
Menadione—PROS1—Cell surface interactions at the vascular wall—SELP—systemic scleroderma	0.00119	0.0138	CbGpPWpGaD
Menadione—GGCX—tendon—systemic scleroderma	0.00117	0.0068	CbGeAlD
Menadione—PROS1—digestive system—systemic scleroderma	0.00117	0.00678	CbGeAlD
Menadione—F10—Beta2 integrin cell surface interactions—CD40LG—systemic scleroderma	0.00114	0.0132	CbGpPWpGaD
Menadione—PROS1—tendon—systemic scleroderma	0.00111	0.00646	CbGeAlD
Menadione—MTHFR—Folate Metabolism—CSF1—systemic scleroderma	0.00109	0.0125	CbGpPWpGaD
Menadione—F2—connective tissue—systemic scleroderma	0.00109	0.0063	CbGeAlD
Menadione—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—systemic scleroderma	0.00108	0.0125	CbGpPWpGaD
Menadione—PROC—Cell surface interactions at the vascular wall—ITGAM—systemic scleroderma	0.00108	0.0124	CbGpPWpGaD
Menadione—F10—tendon—systemic scleroderma	0.00105	0.00608	CbGeAlD
Menadione—F2—Platelet Aggregation (Plug Formation)—CSK—systemic scleroderma	0.00105	0.0121	CbGpPWpGaD
Menadione—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—systemic scleroderma	0.00103	0.0119	CbGpPWpGaD
Menadione—GGCX—lung—systemic scleroderma	0.00103	0.00597	CbGeAlD
Menadione—PROS1—lung—systemic scleroderma	0.000976	0.00567	CbGeAlD
Menadione—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—systemic scleroderma	0.000966	0.0111	CbGpPWpGaD
Menadione—PROS1—Cell surface interactions at the vascular wall—ITGAM—systemic scleroderma	0.000954	0.011	CbGpPWpGaD
Menadione—XDH—digestive system—systemic scleroderma	0.000944	0.00548	CbGeAlD
Menadione—F10—lung—systemic scleroderma	0.000919	0.00533	CbGeAlD
Menadione—NQO1—connective tissue—systemic scleroderma	0.000905	0.00525	CbGeAlD
Menadione—F7—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.000891	0.0103	CbGpPWpGaD
Menadione—VKORC1—lung—systemic scleroderma	0.000881	0.00511	CbGeAlD
Menadione—NQO1—smooth muscle tissue—systemic scleroderma	0.000828	0.00481	CbGeAlD
Menadione—NQO1—skin of body—systemic scleroderma	0.000817	0.00474	CbGeAlD
Menadione—MTHFR—digestive system—systemic scleroderma	0.000784	0.00455	CbGeAlD
Menadione—F2—digestive system—systemic scleroderma	0.000784	0.00455	CbGeAlD
Menadione—F2—Regulation of IGF Activity by IGFBP—MMP1—systemic scleroderma	0.000776	0.00895	CbGpPWpGaD
Menadione—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—systemic scleroderma	0.000775	0.00894	CbGpPWpGaD
Menadione—F2—Folate Metabolism—CSF1—systemic scleroderma	0.000747	0.00862	CbGpPWpGaD
Menadione—NQO2—tendon—systemic scleroderma	0.000743	0.00431	CbGeAlD
Menadione—F7—Folate Metabolism—CCL2—systemic scleroderma	0.000725	0.00837	CbGpPWpGaD
Menadione—BGLAP—Glucocorticoid receptor regulatory network—MMP1—systemic scleroderma	0.000705	0.00813	CbGpPWpGaD
Menadione—F7—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.000676	0.0078	CbGpPWpGaD
Menadione—MTHFR—lung—systemic scleroderma	0.000655	0.0038	CbGeAlD
Menadione—F2—lung—systemic scleroderma	0.000655	0.0038	CbGeAlD
Menadione—NQO1—digestive system—systemic scleroderma	0.000654	0.00379	CbGeAlD
Menadione—NQO2—lung—systemic scleroderma	0.000652	0.00379	CbGeAlD
Menadione—MAOB—connective tissue—systemic scleroderma	0.00064	0.00371	CbGeAlD
Menadione—PROS1—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.000628	0.00724	CbGpPWpGaD
Menadione—NQO1—tendon—systemic scleroderma	0.000622	0.00361	CbGeAlD
Menadione—F2—Regulation of IGF Activity by IGFBP—MMP2—systemic scleroderma	0.0006	0.00692	CbGpPWpGaD
Menadione—AOX1—digestive system—systemic scleroderma	0.0006	0.00348	CbGeAlD
Menadione—PROS1—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.000586	0.00676	CbGpPWpGaD
Menadione—F7—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000576	0.00665	CbGpPWpGaD
Menadione—BGLAP—FGF signaling pathway—MMP9—systemic scleroderma	0.000573	0.00661	CbGpPWpGaD
Menadione—AOX1—tendon—systemic scleroderma	0.000571	0.00331	CbGeAlD
Menadione—F2—IL1 and megakaryotyces in obesity—CCL2—systemic scleroderma	0.000567	0.00654	CbGpPWpGaD
Menadione—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—systemic scleroderma	0.000563	0.0065	CbGpPWpGaD
Menadione—F2—Cell surface interactions at the vascular wall—SELP—systemic scleroderma	0.00056	0.00646	CbGpPWpGaD
Menadione—BGLAP—Interleukin-11 Signaling Pathway—TGFB1—systemic scleroderma	0.000556	0.00641	CbGpPWpGaD
Menadione—F7—Folate Metabolism—IL1B—systemic scleroderma	0.00055	0.00635	CbGpPWpGaD
Menadione—NQO1—lung—systemic scleroderma	0.000546	0.00317	CbGeAlD
Menadione—PROC—Cell surface interactions at the vascular wall—MMP1—systemic scleroderma	0.00054	0.00623	CbGpPWpGaD
Menadione—PROS1—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	0.000534	0.00616	CbGpPWpGaD
Menadione—CYP2A6—lung—systemic scleroderma	0.000523	0.00304	CbGeAlD
Menadione—AOX1—lung—systemic scleroderma	0.000501	0.00291	CbGeAlD
Menadione—F9—Hemostasis—SELP—systemic scleroderma	0.000497	0.00573	CbGpPWpGaD
Menadione—PROS1—Cell surface interactions at the vascular wall—MMP1—systemic scleroderma	0.000478	0.00552	CbGpPWpGaD
Menadione—F9—Hemostasis—RHOB—systemic scleroderma	0.000464	0.00535	CbGpPWpGaD
Menadione—MAOB—digestive system—systemic scleroderma	0.000462	0.00268	CbGeAlD
Menadione—MTHFR—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.000451	0.0052	CbGpPWpGaD
Menadione—F2—Cell surface interactions at the vascular wall—ITGAM—systemic scleroderma	0.000448	0.00516	CbGpPWpGaD
Menadione—MAOB—tendon—systemic scleroderma	0.00044	0.00255	CbGeAlD
Menadione—F7—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000437	0.00504	CbGpPWpGaD
Menadione—F7—Hemostasis—SELP—systemic scleroderma	0.000436	0.00503	CbGpPWpGaD
Menadione—F2—IL1 and megakaryotyces in obesity—IL1B—systemic scleroderma	0.00043	0.00496	CbGpPWpGaD
Menadione—F9—Hemostasis—CSK—systemic scleroderma	0.000423	0.00488	CbGpPWpGaD
Menadione—F7—Hemostasis—RHOB—systemic scleroderma	0.000407	0.0047	CbGpPWpGaD
Menadione—CYP1A1—skin of body—systemic scleroderma	0.000406	0.00235	CbGeAlD
Menadione—F2—IL1 and megakaryotyces in obesity—MMP9—systemic scleroderma	0.000405	0.00468	CbGpPWpGaD
Menadione—F9—Hemostasis—ITGAM—systemic scleroderma	0.000397	0.00458	CbGpPWpGaD
Menadione—MAOB—lung—systemic scleroderma	0.000386	0.00224	CbGeAlD
Menadione—NQO1—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	0.000376	0.00434	CbGpPWpGaD
Menadione—F7—Hemostasis—CSK—systemic scleroderma	0.000371	0.00428	CbGpPWpGaD
Menadione—MTHFR—Folate Metabolism—CCL2—systemic scleroderma	0.000367	0.00423	CbGpPWpGaD
Menadione—PROC—Hemostasis—SELP—systemic scleroderma	0.000366	0.00422	CbGpPWpGaD
Menadione—F7—Hemostasis—ITGAM—systemic scleroderma	0.000349	0.00402	CbGpPWpGaD
Menadione—F2—Regulation of Actin Cytoskeleton—CSK—systemic scleroderma	0.000343	0.00396	CbGpPWpGaD
Menadione—MTHFR—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.000342	0.00394	CbGpPWpGaD
Menadione—PROC—Hemostasis—RHOB—systemic scleroderma	0.000341	0.00394	CbGpPWpGaD
Menadione—CYP1A2—digestive system—systemic scleroderma	0.000329	0.00191	CbGeAlD
Menadione—CYP1A1—digestive system—systemic scleroderma	0.000324	0.00188	CbGeAlD
Menadione—PROS1—Hemostasis—SELP—systemic scleroderma	0.000324	0.00373	CbGpPWpGaD
Menadione—F2—Syndecan-4-mediated signaling events—MMP9—systemic scleroderma	0.000322	0.00372	CbGpPWpGaD
Menadione—F2—PAR1-mediated thrombin signaling events—NOS3—systemic scleroderma	0.000317	0.00366	CbGpPWpGaD
Menadione—PROZ—Metabolism of proteins—ACE—systemic scleroderma	0.000313	0.00361	CbGpPWpGaD
Menadione—PROC—Hemostasis—CSK—systemic scleroderma	0.000311	0.00359	CbGpPWpGaD
Menadione—CYP1A1—Melatonin metabolism and effects—EDN1—systemic scleroderma	0.00031	0.00358	CbGpPWpGaD
Menadione—F2—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.00031	0.00358	CbGpPWpGaD
Menadione—PROS1—Hemostasis—RHOB—systemic scleroderma	0.000302	0.00349	CbGpPWpGaD
Menadione—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—systemic scleroderma	0.0003	0.00346	CbGpPWpGaD
Menadione—CYP2E1—digestive system—systemic scleroderma	0.000296	0.00172	CbGeAlD
Menadione—F2—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.000295	0.0034	CbGpPWpGaD
Menadione—PROC—Hemostasis—ITGAM—systemic scleroderma	0.000292	0.00337	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000292	0.00337	CbGpPWpGaD
Menadione—MTHFR—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000291	0.00336	CbGpPWpGaD
Menadione—CYP2E1—tendon—systemic scleroderma	0.000282	0.00163	CbGeAlD
Menadione—F2—Angiopoietin receptor Tie2-mediated signaling—NOS3—systemic scleroderma	0.000281	0.00324	CbGpPWpGaD
Menadione—MTHFR—Folate Metabolism—IL1B—systemic scleroderma	0.000278	0.00321	CbGpPWpGaD
Menadione—PROS1—Hemostasis—CSK—systemic scleroderma	0.000275	0.00317	CbGpPWpGaD
Menadione—F2—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.000275	0.00317	CbGpPWpGaD
Menadione—CYP1A2—lung—systemic scleroderma	0.000275	0.00159	CbGeAlD
Menadione—PROS1—Platelet degranulation—TGFB1—systemic scleroderma	0.000272	0.00314	CbGpPWpGaD
Menadione—CYP1A1—lung—systemic scleroderma	0.000271	0.00157	CbGeAlD
Menadione—XDH—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000265	0.00305	CbGpPWpGaD
Menadione—PROS1—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.000259	0.00299	CbGpPWpGaD
Menadione—PROS1—Hemostasis—ITGAM—systemic scleroderma	0.000259	0.00298	CbGpPWpGaD
Menadione—F2—Folate Metabolism—CCL2—systemic scleroderma	0.000252	0.00291	CbGpPWpGaD
Menadione—F2—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	0.00025	0.00289	CbGpPWpGaD
Menadione—CYP2E1—lung—systemic scleroderma	0.000247	0.00143	CbGeAlD
Menadione—F10—Hemostasis—SELP—systemic scleroderma	0.000247	0.00284	CbGpPWpGaD
Menadione—F9—Metabolism of proteins—ACE—systemic scleroderma	0.000244	0.00281	CbGpPWpGaD
Menadione—F2—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.000235	0.00271	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—ITGAM—systemic scleroderma	0.000233	0.00269	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—CD247—systemic scleroderma	0.000233	0.00269	CbGpPWpGaD
Menadione—GGCX—Metabolism of proteins—ACE—systemic scleroderma	0.00023	0.00266	CbGpPWpGaD
Menadione—F10—Hemostasis—RHOB—systemic scleroderma	0.00023	0.00266	CbGpPWpGaD
Menadione—F2—Cell surface interactions at the vascular wall—MMP1—systemic scleroderma	0.000224	0.00259	CbGpPWpGaD
Menadione—MTHFR—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000221	0.00255	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—TNFAIP3—systemic scleroderma	0.000218	0.00252	CbGpPWpGaD
Menadione—F7—Metabolism of proteins—ACE—systemic scleroderma	0.000214	0.00247	CbGpPWpGaD
Menadione—F10—Hemostasis—CSK—systemic scleroderma	0.00021	0.00242	CbGpPWpGaD
Menadione—XDH—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000201	0.00231	CbGpPWpGaD
Menadione—PROZ—Metabolism of proteins—MMP1—systemic scleroderma	0.000201	0.00231	CbGpPWpGaD
Menadione—F2—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.0002	0.00231	CbGpPWpGaD
Menadione—F9—Hemostasis—MMP1—systemic scleroderma	0.000199	0.0023	CbGpPWpGaD
Menadione—CYP1A2—Melatonin metabolism and effects—EDN1—systemic scleroderma	0.000198	0.00228	CbGpPWpGaD
Menadione—F10—Hemostasis—ITGAM—systemic scleroderma	0.000197	0.00227	CbGpPWpGaD
Menadione—F2—Folate Metabolism—IL1B—systemic scleroderma	0.000191	0.00221	CbGpPWpGaD
Menadione—VKORC1—Metabolism of proteins—ACE—systemic scleroderma	0.000191	0.0022	CbGpPWpGaD
Menadione—PROC—Metabolism of proteins—ACE—systemic scleroderma	0.00018	0.00207	CbGpPWpGaD
Menadione—F7—Hemostasis—MMP1—systemic scleroderma	0.000175	0.00202	CbGpPWpGaD
Menadione—PROZ—Metabolism of proteins—CCL2—systemic scleroderma	0.000163	0.00188	CbGpPWpGaD
Menadione—F2—G alpha (q) signalling events—EDN1—systemic scleroderma	0.00016	0.00185	CbGpPWpGaD
Menadione—PROS1—Metabolism of proteins—ACE—systemic scleroderma	0.000159	0.00183	CbGpPWpGaD
Menadione—F2—Peptide ligand-binding receptors—EDN1—systemic scleroderma	0.000158	0.00183	CbGpPWpGaD
Menadione—F9—Metabolism of proteins—MMP1—systemic scleroderma	0.000157	0.00181	CbGpPWpGaD
Menadione—PROZ—Metabolism of proteins—MMP2—systemic scleroderma	0.000155	0.00179	CbGpPWpGaD
Menadione—F2—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000152	0.00175	CbGpPWpGaD
Menadione—F2—Hemostasis—SELP—systemic scleroderma	0.000152	0.00175	CbGpPWpGaD
Menadione—CYP1A1—PPARA activates gene expression—CTGF—systemic scleroderma	0.000149	0.00172	CbGpPWpGaD
Menadione—GGCX—Metabolism of proteins—MMP1—systemic scleroderma	0.000148	0.00171	CbGpPWpGaD
Menadione—PROC—Hemostasis—MMP1—systemic scleroderma	0.000146	0.00169	CbGpPWpGaD
Menadione—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—systemic scleroderma	0.000146	0.00169	CbGpPWpGaD
Menadione—F9—Hemostasis—NOS3—systemic scleroderma	0.000144	0.00167	CbGpPWpGaD
Menadione—PROS1—Immune System—CSK—systemic scleroderma	0.000144	0.00166	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—systemic scleroderma	0.000144	0.00166	CbGpPWpGaD
Menadione—PROS1—Immune System—IRF5—systemic scleroderma	0.000142	0.00164	CbGpPWpGaD
Menadione—F2—Hemostasis—RHOB—systemic scleroderma	0.000142	0.00164	CbGpPWpGaD
Menadione—F7—Metabolism of proteins—MMP1—systemic scleroderma	0.000138	0.00159	CbGpPWpGaD
Menadione—PROS1—Immune System—IRF8—systemic scleroderma	0.000136	0.00157	CbGpPWpGaD
Menadione—PROS1—Immune System—ITGAM—systemic scleroderma	0.000136	0.00157	CbGpPWpGaD
Menadione—PROS1—Immune System—CD247—systemic scleroderma	0.000136	0.00157	CbGpPWpGaD
Menadione—PROS1—Hemostasis—MMP1—systemic scleroderma	0.00013	0.0015	CbGpPWpGaD
Menadione—F2—Hemostasis—CSK—systemic scleroderma	0.000129	0.00149	CbGpPWpGaD
Menadione—MTHFR—Disease—SMAD7—systemic scleroderma	0.000129	0.00149	CbGpPWpGaD
Menadione—F9—Metabolism of proteins—CCL2—systemic scleroderma	0.000127	0.00147	CbGpPWpGaD
Menadione—PROS1—Immune System—TNFAIP3—systemic scleroderma	0.000127	0.00147	CbGpPWpGaD
Menadione—F7—Hemostasis—NOS3—systemic scleroderma	0.000127	0.00146	CbGpPWpGaD
Menadione—AOX1—Disease—SMAD7—systemic scleroderma	0.000126	0.00145	CbGpPWpGaD
Menadione—PROS1—Immune System—BLK—systemic scleroderma	0.000126	0.00145	CbGpPWpGaD
Menadione—VKORC1—Metabolism of proteins—MMP1—systemic scleroderma	0.000123	0.00141	CbGpPWpGaD
Menadione—F2—Hemostasis—ITGAM—systemic scleroderma	0.000121	0.0014	CbGpPWpGaD
Menadione—F9—Metabolism of proteins—MMP2—systemic scleroderma	0.000121	0.0014	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—ACE—systemic scleroderma	0.000121	0.0014	CbGpPWpGaD
Menadione—PROS1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000121	0.00139	CbGpPWpGaD
Menadione—GGCX—Metabolism of proteins—CCL2—systemic scleroderma	0.00012	0.00139	CbGpPWpGaD
Menadione—MTHFR—Disease—TGFBI—systemic scleroderma	0.000118	0.00136	CbGpPWpGaD
Menadione—NQO1—NRF2 pathway—TGFB1—systemic scleroderma	0.000116	0.00134	CbGpPWpGaD
Menadione—PROC—Metabolism of proteins—MMP1—systemic scleroderma	0.000115	0.00133	CbGpPWpGaD
Menadione—AOX1—Disease—TGFBI—systemic scleroderma	0.000115	0.00133	CbGpPWpGaD
Menadione—GGCX—Metabolism of proteins—MMP2—systemic scleroderma	0.000114	0.00132	CbGpPWpGaD
Menadione—F7—Metabolism of proteins—CCL2—systemic scleroderma	0.000112	0.00129	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	0.000111	0.00128	CbGpPWpGaD
Menadione—F2—Peptide ligand-binding receptors—CCL2—systemic scleroderma	0.000108	0.00125	CbGpPWpGaD
Menadione—F7—Metabolism of proteins—MMP2—systemic scleroderma	0.000106	0.00123	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	0.000106	0.00123	CbGpPWpGaD
Menadione—PROC—Hemostasis—NOS3—systemic scleroderma	0.000106	0.00123	CbGpPWpGaD
Menadione—PROS1—Immune System—CTLA4—systemic scleroderma	0.000103	0.00119	CbGpPWpGaD
Menadione—PROS1—Metabolism of proteins—MMP1—systemic scleroderma	0.000102	0.00118	CbGpPWpGaD
Menadione—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	0.000101	0.00116	CbGpPWpGaD
Menadione—VKORC1—Metabolism of proteins—CCL2—systemic scleroderma	9.97e-05	0.00115	CbGpPWpGaD
Menadione—F10—Hemostasis—MMP1—systemic scleroderma	9.88e-05	0.00114	CbGpPWpGaD
Menadione—F9—Hemostasis—TGFB1—systemic scleroderma	9.54e-05	0.0011	CbGpPWpGaD
Menadione—VKORC1—Metabolism of proteins—MMP2—systemic scleroderma	9.48e-05	0.00109	CbGpPWpGaD
Menadione—MTHFR—Disease—HSPG2—systemic scleroderma	9.4e-05	0.00108	CbGpPWpGaD
Menadione—PROS1—Hemostasis—NOS3—systemic scleroderma	9.4e-05	0.00108	CbGpPWpGaD
Menadione—PROC—Metabolism of proteins—CCL2—systemic scleroderma	9.37e-05	0.00108	CbGpPWpGaD
Menadione—AOX1—Disease—HSPG2—systemic scleroderma	9.19e-05	0.00106	CbGpPWpGaD
Menadione—MTHFR—Disease—CSK—systemic scleroderma	9.08e-05	0.00105	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—RHOB—systemic scleroderma	8.96e-05	0.00103	CbGpPWpGaD
Menadione—PROC—Metabolism of proteins—MMP2—systemic scleroderma	8.92e-05	0.00103	CbGpPWpGaD
Menadione—AOX1—Disease—CSK—systemic scleroderma	8.87e-05	0.00102	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	8.64e-05	0.000997	CbGpPWpGaD
Menadione—MTHFR—Disease—CD247—systemic scleroderma	8.54e-05	0.000985	CbGpPWpGaD
Menadione—PROS1—Immune System—HLA-DQB1—systemic scleroderma	8.47e-05	0.000977	CbGpPWpGaD
Menadione—F7—Hemostasis—TGFB1—systemic scleroderma	8.38e-05	0.000967	CbGpPWpGaD
Menadione—AOX1—Disease—CD247—systemic scleroderma	8.34e-05	0.000962	CbGpPWpGaD
Menadione—PROS1—Metabolism of proteins—CCL2—systemic scleroderma	8.29e-05	0.000957	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—RHOB—systemic scleroderma	8.13e-05	0.000939	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—EDN1—systemic scleroderma	8.09e-05	0.000934	CbGpPWpGaD
Menadione—PROS1—Immune System—IL1A—systemic scleroderma	8.04e-05	0.000928	CbGpPWpGaD
Menadione—PROS1—Immune System—CD40LG—systemic scleroderma	7.99e-05	0.000922	CbGpPWpGaD
Menadione—NQO1—Metabolism—HSPG2—systemic scleroderma	7.97e-05	0.00092	CbGpPWpGaD
Menadione—PROS1—Metabolism of proteins—MMP2—systemic scleroderma	7.89e-05	0.00091	CbGpPWpGaD
Menadione—MTHFR—Metabolism—HSPG2—systemic scleroderma	7.88e-05	0.000909	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—MMP1—systemic scleroderma	7.77e-05	0.000896	CbGpPWpGaD
Menadione—AOX1—Metabolism—HSPG2—systemic scleroderma	7.69e-05	0.000887	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—ACE—systemic scleroderma	7.45e-05	0.00086	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	7.27e-05	0.000838	CbGpPWpGaD
Menadione—F10—Hemostasis—NOS3—systemic scleroderma	7.16e-05	0.000826	CbGpPWpGaD
Menadione—XDH—Metabolism—HSPG2—systemic scleroderma	7.15e-05	0.000825	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	7.09e-05	0.000818	CbGpPWpGaD
Menadione—PROC—Hemostasis—TGFB1—systemic scleroderma	7.02e-05	0.00081	CbGpPWpGaD
Menadione—MAOB—Metabolism—HSPG2—systemic scleroderma	6.5e-05	0.00075	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—CCL2—systemic scleroderma	6.32e-05	0.000729	CbGpPWpGaD
Menadione—PROS1—Hemostasis—TGFB1—systemic scleroderma	6.21e-05	0.000717	CbGpPWpGaD
Menadione—F2—Signaling Pathways—SMAD7—systemic scleroderma	6.21e-05	0.000717	CbGpPWpGaD
Menadione—F2—Hemostasis—MMP1—systemic scleroderma	6.08e-05	0.000702	CbGpPWpGaD
Menadione—NQO1—Metabolism—CTGF—systemic scleroderma	6.04e-05	0.000697	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—MMP2—systemic scleroderma	6.01e-05	0.000694	CbGpPWpGaD
Menadione—MTHFR—Metabolism—CTGF—systemic scleroderma	5.97e-05	0.000689	CbGpPWpGaD
Menadione—AOX1—Metabolism—CTGF—systemic scleroderma	5.83e-05	0.000673	CbGpPWpGaD
Menadione—F2—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	5.66e-05	0.000653	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—CCL2—systemic scleroderma	5.53e-05	0.000638	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	5.51e-05	0.000636	CbGpPWpGaD
Menadione—XDH—Metabolism—CTGF—systemic scleroderma	5.42e-05	0.000625	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	5.3e-05	0.000611	CbGpPWpGaD
Menadione—MAOB—Metabolism—CTGF—systemic scleroderma	4.93e-05	0.000568	CbGpPWpGaD
Menadione—F2—Signaling Pathways—RHOB—systemic scleroderma	4.81e-05	0.000554	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—MMP1—systemic scleroderma	4.79e-05	0.000552	CbGpPWpGaD
Menadione—F10—Hemostasis—TGFB1—systemic scleroderma	4.73e-05	0.000546	CbGpPWpGaD
Menadione—CYP2A6—NRF2 pathway—TGFB1—systemic scleroderma	4.6e-05	0.000531	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—EDN1—systemic scleroderma	4.57e-05	0.000528	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HSPG2—systemic scleroderma	4.53e-05	0.000523	CbGpPWpGaD
Menadione—F2—Hemostasis—NOS3—systemic scleroderma	4.41e-05	0.000509	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CSK—systemic scleroderma	4.38e-05	0.000505	CbGpPWpGaD
Menadione—PROS1—Immune System—IL1B—systemic scleroderma	4.19e-05	0.000484	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—EDN1—systemic scleroderma	4.15e-05	0.000479	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.01e-05	0.000463	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—CCL2—systemic scleroderma	3.89e-05	0.000449	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—MMP2—systemic scleroderma	3.7e-05	0.000427	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	3.38e-05	0.00039	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—HSPG2—systemic scleroderma	3.17e-05	0.000365	CbGpPWpGaD
Menadione—MTHFR—Disease—NOS3—systemic scleroderma	3.1e-05	0.000358	CbGpPWpGaD
Menadione—AOX1—Disease—NOS3—systemic scleroderma	3.03e-05	0.00035	CbGpPWpGaD
Menadione—F2—Hemostasis—TGFB1—systemic scleroderma	2.92e-05	0.000336	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—CCL2—systemic scleroderma	2.84e-05	0.000328	CbGpPWpGaD
Menadione—NQO1—Metabolism—NOS3—systemic scleroderma	2.63e-05	0.000303	CbGpPWpGaD
Menadione—MTHFR—Metabolism—NOS3—systemic scleroderma	2.6e-05	0.0003	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.56e-05	0.000295	CbGpPWpGaD
Menadione—AOX1—Metabolism—NOS3—systemic scleroderma	2.54e-05	0.000293	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—HSPG2—systemic scleroderma	2.5e-05	0.000289	CbGpPWpGaD
Menadione—F2—Signaling Pathways—EDN1—systemic scleroderma	2.45e-05	0.000283	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CTGF—systemic scleroderma	2.4e-05	0.000277	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—HSPG2—systemic scleroderma	2.36e-05	0.000272	CbGpPWpGaD
Menadione—XDH—Metabolism—NOS3—systemic scleroderma	2.36e-05	0.000272	CbGpPWpGaD
Menadione—MAOB—Metabolism—NOS3—systemic scleroderma	2.14e-05	0.000247	CbGpPWpGaD
Menadione—MTHFR—Disease—TGFB1—systemic scleroderma	2.05e-05	0.000237	CbGpPWpGaD
Menadione—AOX1—Disease—TGFB1—systemic scleroderma	2e-05	0.000231	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CTGF—systemic scleroderma	1.9e-05	0.000219	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CTGF—systemic scleroderma	1.79e-05	0.000206	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CCL2—systemic scleroderma	1.68e-05	0.000194	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—HSPG2—systemic scleroderma	1.5e-05	0.000174	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NOS3—systemic scleroderma	1.49e-05	0.000172	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MMP9—systemic scleroderma	1.2e-05	0.000138	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CTGF—systemic scleroderma	1.14e-05	0.000132	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—NOS3—systemic scleroderma	1.04e-05	0.000121	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TGFB1—systemic scleroderma	9.89e-06	0.000114	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—NOS3—systemic scleroderma	8.25e-06	9.52e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—NOS3—systemic scleroderma	7.78e-06	8.98e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—NOS3—systemic scleroderma	4.96e-06	5.72e-05	CbGpPWpGaD
